References
- Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations
of COVID-19. Nat Med . 2020;26(7):1017-1032.
- Goldenberg NA, Sochet A, Albisetti M, et al. Consensus-based clinical
recommendations and research priorities for anticoagulant
thromboprophylaxis in children hospitalized for COVID-19-related
illness. J ThrombHaemost . 2020;18(11):3099-3105.
- Loi M, Branchford B, Kim J, Self C, Nuss R. COVID-19 anticoagulation
recommendations in children. Pediatr Blood Cancer .
2020;67(9):e28485.
- Mathuria JP, Yadav R, Rajkumar. Laboratory diagnosis of SARS-CoV-2 - A
review of current methods. J Infect Public Health .
2020;13(7):901-905.
- Kotula JJ, Balakumar N, Khan D, Patel B. Bilateral pulmonary emboli in
a teenager with positive SARS-CoV-2 antibody. PediatrPulmonol .
2021;56(1):271-273.
- Martinelli I, Ferrazzi E, Ciavarella A, et al. Pulmonary embolism in a
young pregnant woman with COVID-19. Thromb Res . 2020;191:36-37.
- Hussain Z, Wangmo R, Gonbo S. Deep Vein Thrombosis After Trivial Blunt
Trauma at High Altitude in a SARS-CoV-2 Positive Child: Complication
of the Hypercoagulable State. Indian Pediatr .
2020;57(12):1182-1183.
- Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic
complications in critically ill ICU patients with COVID-19.Thromb Res . 2020;191:145-147.
- Iba T, Levy JH, Levi M, Connors JM, Thachil J. Coagulopathy of
Coronavirus Disease 2019. Crit Care Med . 2020;48(9):1358-1364.
- Middeldorp S, Coppens M, van Haaps TF, et al. Incidence of venous
thromboembolism in hospitalized patients with COVID-19. J
ThrombHaemost . 2020;18(8):1995-2002.
- Thachil J, Srivastava A. SARS-2 Coronavirus-Associated Hemostatic Lung
Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary
Embolism?.Semin ThrombHemost . 2020;46(7):777-780.
- Branchford BR, Mahajerin A, Raffini L, et al. Recommendations for
standardized risk factor definitions in pediatric hospital-acquired
venous thromboembolism to inform future prevention trials:
communication from the SSC of the ISTH. J Thromb Haemost .
2017;15(11):2274-2278.
- Wit JM, Hero M, Nunez SB. Aromatase inhibitors in pediatrics.Nat Rev Endocrinol . 2011;8(3):135-147.
- Baum M, Buzdar A, Cuzick J, et al. Anastrozole alone or in combination
with tamoxifen versus tamoxifen alone for adjuvant treatment of
postmenopausal women with early-stage breast cancer: results of the
ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and
safety update analyses. Cancer. 2003;98(9):1802-1810.
- Diaz-Thomas A, Shulman D. Use of aromatase inhibitors in children and
adolescents: what’s new?. Curr Opin Pediatr.2010;22(4):501-507.
- Zhou B, She J, Wang Y, Ma X. Venous thrombosis and arteriosclerosis
obliterans of lower extremities in a very severe patient with 2019
novel coronavirus disease: a case report. J Thromb
Thrombolysis . 2020;50(1):229-232.
- Franch-Llasat D, Mayor-Vázquez E, Pedregosa-Díaz J, Herrero-Redondo M,
Ortin-Font X, Roche-Campo F. e-Thrombosis in the COVID-19 era:
collateral effects of confinement. Med Intensiva .
2020;S0210-5691(20)30265-5.
- Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The
hypercoagulable state in COVID-19: Incidence, pathophysiology, and
management. Thromb Res . 2020;194:101-115.
- Colling ME, Kanthi Y. COVID-19-associated coagulopathy: An exploration
of mechanisms. Vasc Med . 2020;25(5):471-478.
- Jayarangaiah A, Kariyanna PT, Chen X, Jayarangaiah A, Kumar A.
COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis
Response. Clin Appl ThrombHemost . 2020;26:1076029620943293.
- Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the
cornerstone of organ dysfunction in severe SARS-CoV-2 infection.Crit Care. 2020;24(1):353.
- Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and
endotheliitis in COVID-19. Lancet . 2020;395(10234):1417-1418.
- Müller MM, Griesmacher A. Markers of endothelial dysfunction.Clin Chem Lab Med . 2000;38(2):77-85.
- Rauch A, Labreuche J, Lassalle F, Goutay J, Caplan M, Charbonnier L et
al. Coagulation biomarkers are independent predictors of increased
oxygen requirements in COVID-19. J Thromb Haemost .
2020;18(11):2942-53.
- Levi M, Iba T. COVID-19 coagulopathy: is it disseminated intravascular
coagulation?. Intern Emerg Med . 2020;1-4.
- Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. The
unique characteristics of COVID-19 coagulopathy. Crit Care.2020;24(1):360.
- Gazzaruso C, Paolozzi E, Valenti C, et al. Association between
antithrombin and mortality in patients with COVID-19. A possible link
with obesity. Nutr Metab Cardiovasc Dis . 2020;30(11):1914-1919.
- Maldonado E, Tao D, Mackey K. Antithrombotic Therapies in COVID-19
Disease: a Systematic Review. J Gen Intern Med. 2020;35(9):2698-2706.
- Lippi G, Henry BM, Sanchis-Gomar F. Plasma Antithrombin Values Are
Significantly Decreased in Coronavirus Disease 2019 (COVID-19)
Patients with Severe Illness [published online ahead of print, 2020
Dec 30]. Semin Thromb Hemost . 2020;10.1055/s-0040-1716873.